Fibromyalgia
Conditions
Brief summary
Fibromyalgia is a complex chronic illness affecting 6-12 million Americans. Self-management strategies play a key role in reducing symptoms and maintaining functioning. The proposed project offers a web-based self management tool that enables FM sufferers to identify significant linkages between their personal symptom levels and their personal self-management efforts over time in order to plan their own optimal approach to disease management.
Detailed description
This Phase II project will complete development of the SMART (Self-Monitoring and Review Tool) Log program for symptom management and health promotion in FM and evaluate its efficacy in a large web-based trial that will closely emulate its planned application in Phase III. The SMARTLog program is an interactive web-based self-monitoring and feedback intervention that employs proprietary statistical analysis procedures to give the user personally optimized guidance on behavioral, lifestyle and coping strategies that yield effective symptom reduction for that individual. The program incorporates longitudinal collection and analysis of the individual's self-monitoring data followed by delivery of personalized feedback derived from those same personal data. The program helps FM sufferers discover and monitor linkages between specific personal health-related behaviors and management strategies and their symptom levels over time. Feasibility was demonstrated in Phase I by very high retention rates, ratings of satisfaction and perceived relevance, evidence of impact of utilization on improved well-being over the use period, and qualitative data indicating strong interest in continuation with the program.
Interventions
BEHAVIORALThe Fibromyalgia Wellness Project
Web-based symptom and behavior self-monitoring program with automated feedback derived from the user's personal data. A personal informatics approach is used involving proprietary within-subject statistical analysis procedures to determine user feedback that provides behavioral guidance based on statistically significant change in symptom levels associated with specific user behavior and self-management strategies.
Sponsors
Collinge and Associates, Inc.
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Self-reported presence of fibromyalgia
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in daily symptom Levels | Baseline to user-defined end date (variable time series design) up to 9 months | Change in Likert-scaled (0-10) daily symptom severity levels on the SMARTLog tracking instrument. Daily reported levels over multiple days are aggregated to calculate trends over the user-defined reporting period. |
Secondary
| Measure | Time frame |
|---|---|
| Change in Fibromyalgia Impact Questionnaire scores | Baseline to user-defined end date (variable time series design) up to 9 months |
| Change in Self-Efficacy for Chronic Disease Scale scores | Baseline to user-defined end date (variable time series design) up to 9 months |
| Change in SF12 scores | Baseline to user-defined end date (variable time series design) up to 9 months |
| Change in Multi-dimensional Health Locus of Control Scale scores | Baseline to user-defined end date (variable time series design) up to 9 months |
Countries
United States
Outcome results
None listed